PCG Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Buy
232
+4
+2% +$4.09K 0.06% 153
2026
Q1
$210K Buy
+228
New +$231K 0.05% 160

Other funds holding LLY

PCG Wealth Advisors's LLY Position: Q2 2026 in Review

PCG Wealth Advisors increased its Eli Lilly (LLY) stake by 1.8% in Q2 2026, buying an estimated $4.09K and bringing the position to 232 shares worth $279K. The position accounts for 0.06% of the portfolio, ranked #153.

PCG Wealth Advisors first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PCG Wealth Advisors held 232 shares of Eli Lilly worth $279K as of Q2 2026.
  • PCG Wealth Advisors bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.06% of PCG Wealth Advisors's portfolio in Q2 2026, its #153 holding.
  • PCG Wealth Advisors first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PCG Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.